HK1072361A1 - Idraparinux (sanorg 34006) for treatment and secondary prophylaxis of venous thromboemolic events inpatients with deep venous thrombosis - Google Patents

Idraparinux (sanorg 34006) for treatment and secondary prophylaxis of venous thromboemolic events inpatients with deep venous thrombosis

Info

Publication number
HK1072361A1
HK1072361A1 HK05103708A HK05103708A HK1072361A1 HK 1072361 A1 HK1072361 A1 HK 1072361A1 HK 05103708 A HK05103708 A HK 05103708A HK 05103708 A HK05103708 A HK 05103708A HK 1072361 A1 HK1072361 A1 HK 1072361A1
Authority
HK
Hong Kong
Prior art keywords
venous
thromboemolic
sanorg
idraparinux
inpatients
Prior art date
Application number
HK05103708A
Other languages
English (en)
Inventor
Ronald Gijsbertus M Van Amsterdam
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of HK1072361A1 publication Critical patent/HK1072361A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024Esters of saccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
HK05103708A 2002-01-29 2005-05-03 Idraparinux (sanorg 34006) for treatment and secondary prophylaxis of venous thromboemolic events inpatients with deep venous thrombosis HK1072361A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02075374 2002-01-29
PCT/EP2003/000696 WO2003063881A1 (en) 2002-01-29 2003-01-23 Idraparinux(sanorg 34006)for treatment and secondary prophylaxis of venous thromboemolic events in patients with deep venous thrombosis

Publications (1)

Publication Number Publication Date
HK1072361A1 true HK1072361A1 (en) 2005-08-26

Family

ID=27635850

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05103708A HK1072361A1 (en) 2002-01-29 2005-05-03 Idraparinux (sanorg 34006) for treatment and secondary prophylaxis of venous thromboemolic events inpatients with deep venous thrombosis

Country Status (23)

Country Link
US (1) US7709463B2 (xx)
EP (1) EP1471924B1 (xx)
JP (1) JP4870907B2 (xx)
CN (1) CN1622813A (xx)
AR (1) AR038320A1 (xx)
AT (1) ATE323497T1 (xx)
AU (1) AU2003205664B2 (xx)
BR (1) BR0307196A (xx)
CA (1) CA2472957C (xx)
CY (1) CY1107661T1 (xx)
DE (1) DE60304678T2 (xx)
DK (1) DK1471924T3 (xx)
EA (1) EA007204B1 (xx)
ES (1) ES2262971T3 (xx)
HK (1) HK1072361A1 (xx)
MX (1) MXPA04007310A (xx)
NO (1) NO332699B1 (xx)
PE (1) PE20030855A1 (xx)
PL (1) PL207144B1 (xx)
PT (1) PT1471924E (xx)
SI (1) SI1471924T1 (xx)
TW (1) TWI281861B (xx)
WO (1) WO2003063881A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0518794A2 (pt) * 2004-12-01 2008-12-09 Osi Pharm Inc composto, composiÇço, mÉtodo de tratamento de distérbio hiperproliferativo, e, biblioteca combinatorial
US9642822B2 (en) 2011-05-27 2017-05-09 Children's Medical Center Corporation Methods for treating and preventing neutrophil-derived net toxicity and thrombosis
WO2021007429A1 (en) 2019-07-09 2021-01-14 Optimvia Llc Methods for synthesizing anticoagulant polysaccharides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378829A (en) * 1990-04-23 1995-01-03 Akzo N.V. Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type

Also Published As

Publication number Publication date
JP4870907B2 (ja) 2012-02-08
ATE323497T1 (de) 2006-05-15
EP1471924B1 (en) 2006-04-19
PL207144B1 (pl) 2010-11-30
DE60304678D1 (de) 2006-05-24
WO2003063881A1 (en) 2003-08-07
BR0307196A (pt) 2004-11-03
JP2005519919A (ja) 2005-07-07
NO332699B1 (no) 2012-12-10
TWI281861B (en) 2007-06-01
CA2472957C (en) 2011-09-13
ES2262971T3 (es) 2006-12-01
PL370557A1 (en) 2005-05-30
EA200400817A1 (ru) 2005-02-24
DE60304678T2 (de) 2007-04-05
PT1471924E (pt) 2006-09-29
CY1107661T1 (el) 2013-04-18
MXPA04007310A (es) 2004-10-29
US7709463B2 (en) 2010-05-04
AR038320A1 (es) 2005-01-12
TW200302104A (en) 2003-08-01
CN1622813A (zh) 2005-06-01
PE20030855A1 (es) 2003-10-11
CA2472957A1 (en) 2003-08-07
EA007204B1 (ru) 2006-08-25
SI1471924T1 (sl) 2006-10-31
AU2003205664B2 (en) 2008-06-05
US20050209175A1 (en) 2005-09-22
DK1471924T3 (da) 2006-08-21
EP1471924A1 (en) 2004-11-03
NO20043195L (no) 2004-10-29

Similar Documents

Publication Publication Date Title
IL161110A0 (en) Prevention and treatment of restenosis by local admistration of drug
EP1543034A4 (en) TREATMENT AND PROPHYLAXIS WITH 4-1BB BINDING AGENTS
EP1398930A4 (en) HIGH FREQUENCY SIGNAL RECEIVING APPARATUS AND METHOD OF MANUFACTURING THE SAME
IL157577A0 (en) Disposable underpants and method of providing the same
EP1567157A4 (en) METHODS OF USE AND COMPOSITIONS USING IMMUNOMODULATORY COMPOUNDS FOR THE TREATMENT AND MANAGEMENT OF MYELOPROLIFERATIVE SYNDROMES
GB0121155D0 (en) Treatment of substrates
AU2003209851A1 (en) Method of treatment and/or prophylaxis
PL364111A1 (en) Methods of treating inflammatory and immune diseases using inhibitors of ikappab kinase (ikk)
AU2003298803A8 (en) Chamfer hob and method of using same
EP1541733A4 (en) GLOVES AND METHOD FOR KNITTING THESE GLOVES
EP1492902A4 (en) COMPOSITION AND PROCESS FOR TREATING METAL SURFACES
HK1072361A1 (en) Idraparinux (sanorg 34006) for treatment and secondary prophylaxis of venous thromboemolic events inpatients with deep venous thrombosis
GB0115707D0 (en) Treatment and prevention of lipodermatosclerosis
AU2003259202A8 (en) Compositions and methods for treating and preventing infection
EP1472273A4 (en) COMPOSITIONS AND METHODS FOR TREATING IMMUNE DISEASES
GB2395602B (en) MOS transistor and method of manufacturing the same
GB0114572D0 (en) A method for the treatment of textile surfaces and compositions for use therein
GB2410693B (en) Method of ameliorating vision-inhibiting effects of cataracts and the like
EP1284746A4 (en) TREATMENT AND PREVENTION
GB0427237D0 (en) Method of prophylaxis of infection
AU6746501A (en) Methods for prevention of ulcers and improving physiological performance
AU2002357159A8 (en) Manufacture of trialkylaluminum compounds and alpha-alcohols
GB0228998D0 (en) Pipe-in-pipe and method of fabrication thereof
IL161630A0 (en) Methods of treating endometreosis
AUPR626001A0 (en) A method of treatment and/or prophylaxis

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180123